R.W. Roge & Company’s Eli Lilly LLY Stock Holding History

R.W. Roge & Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$429K	Sell	467 -186	-28%	-$189K	0.2%	43
2025 Q4	$701K	Buy	653 +103	+19%	+$98.5K	0.35%	37
2025 Q3	$419K	Hold	550	–	–	0.21%	38
2025 Q2	$428K	Hold	550	–	–	0.24%	36
2025 Q1	$454K	Sell	550 -3	-0.5%	-$2.5K	0.25%	34
2024 Q4	$426K	Hold	553	–	–	0.23%	30
2024 Q3	$489K	Buy	553 +3	+0.5%	+$2.7K	0.26%	29
2024 Q2	$497K	Hold	550	–	–	0.28%	28
2024 Q1	$428K	Hold	550	–	–	0.26%	31
2023 Q4	$320K	Hold	550	–	–	0.21%	35
2023 Q3	$308K	Hold	550	–	–	0.23%	35
2023 Q2	$257K	Buy	+550	New	+$231K	0.18%	35
2023 Q1	–	Sell	-550	Closed	-$201K	–	46
2022 Q4	$201K	Buy	+550	New	+$195K	0.13%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

R.W. Roge & Company's LLY Position: Q1 2026 in Review

R.W. Roge & Company reduced its Eli Lilly (LLY) stake by 28% in Q1 2026, selling an estimated $189K and leaving 467 shares worth $429K. The position accounts for 0.2% of the portfolio, ranked #43.

R.W. Roge & Company first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $701K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

R.W. Roge & Company held 467 shares of Eli Lilly worth $429K as of Q1 2026.
R.W. Roge & Company sold 186 Eli Lilly shares in Q1 2026, an estimated $189K.
Eli Lilly made up 0.2% of R.W. Roge & Company's portfolio in Q1 2026, its #43 holding.
R.W. Roge & Company first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
R.W. Roge & Company's Eli Lilly position peaked at $701K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on R.W. Roge & Company's 13F filing for Q1 2026, filed 1 May 2026.